US EditionTrump order directs federal agencies to reclassify marijuana from Schedule I to Schedule III, reshaping federal drug policy
The executive order aims to speed medical research by reclassifying marijuana to Schedule III, affecting over 6 million patients and 30,000 practitioners, but not legalizing it.
- On Dec. 18, President Donald Trump signed an executive order in the Oval Office to reschedule marijuana from Schedule I to Schedule III with `Today, I'm pleased to announce that I will be signing an executive order to reschedule marijuana from a schedule one to a schedule three controlled substance with legitimate medical uses`, Trump said.
- Since 1970, marijuana was classified as Schedule I with no accepted medical use, while President Joe Biden's review and a 2024 proposed rescheduling rule stalled.
- Industry groups say rescheduling could lower tax burdens, ease banking, and expand research access, while premarket trading showed Tilray shares up nearly 5% and SNDL rising 3%.
- The order directs Attorney General Pam Bondi to hasten rescheduling without a timeline, officials stressed it "is not the legalization" and asks aides to work with Congress and HHS on CBD access and Medicare CBD pilot consideration.
- Advocates welcomed the order and said it enables evidence-based discussions, while Nash County Sheriff Keith Stone raised safety concerns and Florida's 2024 ballot initiative failed despite nearly 56% support.
548 Articles
548 Articles
Federal drug recategorization of cannabis opens doors for pharmaceutical research
NEW MEXICO (KRQE) –President Donald Trump signed an executive order on Thursday downgrading cannabis from Schedule I to Schedule three. For decades, the federal government said cannabis had no medical value, except in a handful of experiments. Now, President Trump's executive order could change that, opening the door for cannabis-based medicines to be made and sold [...]
Green Rush Reloaded: Pot Stocks Soar On Trump Push For Rescheduling
Update (1155ET): Pot stocks soared earlier today after news broke that President Trump is considering directing his administration to reclassify marijuana from Schedule I to Schedule III. Trump has reportedly discussed the idea with HHS Secretary Robert F. Kennedy Jr., CMS Administrator Mehmet Oz, and industry insiders, including Trulieve CEO Kim Rivers and payments executive Howard Kessler. In the markets, Tilray Brands surged 32%, Canopy Growt…
Idaho Press
Trump signs order to loosen federal restrictions on marijuana, but it’s still illegal
President Donald Trump signed an executive order Thursday to loosen federal restrictions on marijuana, which Trump said reflected the drug’s potential medical benefits while discouraging recreational use.
What Trump's rescheduling of marijuana means for Michigan's cannabis industry, research
President Donald Trump signed an executive order Thursday reclassifying marijuana from a Schedule I drug to a Schedule III drug, moving it from a category that includes heroin to one that includes painkillers like Tylenol with codeine.The move represents a significant softening of the federal government's stance on cannabis and could have major implications for both medical research and the cannabis industry. Watch Brett Kast's video report belo…
Trump Signs Executive Order Speeding Reclassification of Cannabis
President Trump signed an executive order Thursday fast-tracking the reclassification of cannabis as a “Schedule III substance,” which would pave the way for the Food and Drug Administration to study its medicinal uses. It’s currently listed under the U.S. Controlled Substances Act as a Schedule I substance — a list that includes heroin, ecstasy and peyote.
Coverage Details
Bias Distribution
- 57% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
